H5N1 vaccines in humans

See on Scoop.it – Virology News

Highlights

•

2 Doses of unadjuvanted vaccine are necessary to elicit robust antibody titers.

•

Oil-in-water adjuvants permit antigen sparing.

•

Antibody titers decline rapidly but can be boosted with additional doses of vaccine.

•

High titers of antibody are associated with cross-reactivity against other clades.

•

Prime-boost strategies elicit a robust immune response.

Ed Rybicki‘s insight:

Thanks @MicrobeTweets!

See on www.sciencedirect.com

This entry was posted on 24 July, 2013 at 10:35 and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

One Response to “H5N1 vaccines in humans”

Outline Science Says:
26 July, 2013 at 17:24 | Reply
Reblogged this on Outline Science.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

ViroBlogy